$BRO

Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents

Brown & Brown, Inc. (NYSE:BRO) reported unaudited Q2 2026 results. Total revenues rose to $1.7 billion, up 30.4% year over year, while organic revenue fell 0.7%. Net income attributable to the company increased to $288 million, and diluted EPS was $0.84. For six months, revenues were $3.6 billion, up 33.0%.

Original reporting
Published Jul 27, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 10:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents — source image
Decision brief

The 30-second read

$BROBullishMed
01

Why it matters

The key trading question is durability: total revenue and net income rose sharply, while organic revenue dipped slightly, suggesting growth mix matters for forward estimates and multiple expansion.

02

Market read

This is a primary earnings release with quantified growth, margins, and organic vs contingents performance that can drive near-term positioning.

03

What to watch

Margin comparisons include non-GAAP adjustments (EBITDAC-adjusted, EPS-adjusted); traders may scrutinize whether adjusted strength reflects sustainable operating performance or accounting/one-off items.

Relevance 8/10Novelty 7/10Timing: after-hours earnings release for Q2 2026 (published 2026-07-27)

Background

Brown & Brown is an insurance brokerage firm reporting quarterly financial results with both GAAP and non-GAAP metrics, including organic revenue and “organic revenue with contingents.”

Company-level read

Ticker impact

$BROBullishHigh confidence
Context

Brown & Brown reported Q2 2026 results: total revenues $1.7B (+30.4% YoY) and net income $288M (+24.7%).

Expected impact

Likely supportive for near-term sentiment, with traders focusing on whether organic weakness persists in the back half.

Evidence & confidence

The release provides multiple hard datapoints (revenue, margins, EPS, and organic vs contingents) that directly inform valuation and forward expectations.

Market effects

As an insurance broker, results can influence read-across sentiment for brokerage peers, especially around organic vs acquisition-driven growth.

No specific regional impact disclosed beyond company-wide financials.

Limited global spillover; primarily a US insurance brokerage earnings datapoint.

Counterpoint

Organic revenue declined (down 0.7% YoY), so the headline growth may be less durable if contingent/acquisition contributions fade.

Key entities

  • Brown & Brown, Inc.

    Reported unaudited Q2 2026 financial results including revenue, earnings, and organic revenue metrics.

  • J. Powell Brown

    CEO who commented on momentum heading into the back half of the year.

Related articles

$BROMed

Why Are Brown & Brown (BRO) Shares Soaring Today

Brown & Brown (NYSE: BRO) shares rose about 5% after the company reported Q2 results. Revenue increased 30.4% year over year to $1.68B, slightly below analysts’ $1.72B estimate. Adjusted EPS was $1.07, in line with expectations, driving investor focus on strong growth despite the revenue miss.

$BROMed

Brown & Brown Q2 Earnings Call Highlights

Brown & Brown (NYSE:BRO) discussed Q2 results on its earnings call. CFO Andy Watts said Retail revenue rose 35.9% mainly from acquisitions, while Retail organic growth was pressured by a pharmacy consulting business and a litigation-related organic revenue adjustment. Specialty Distribution total revenue rose 28.1% on Accession, with EBITDAC margin down to 42.7%. BRO expects H2 Retail organic growth excluding contingents of 1.5% to 2.5% and Specialty 2% to 4%, and reaffirmed $30M-$40M integratio

$BROMedAI 8/10

BROWN & BROWN, INC. (BRO): Results of Operations and Financial Condition

BROWN & BROWN, INC. (BRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bro-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents of 0.7%; diluted net incom

$BROMedAI 8/10

Why Brown & Brown (BRO) Stock Is Down Today

Brown & Brown (NYSE: BRO) shares fell about 2.6% after Morgan Stanley downgraded the stock to Underweight from Equalweight and cut its price target, citing concerns over organic growth reset, a softer pricing cycle, Florida exposure, and tougher competition and hiring. Barclays raised its target to $76 from $72. Shares traded near $68.04.